Cyrus Biotechnology is a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. We are also partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from discovery to the clinic.
Cyrus is based on core software from the lab of David Baker at the University of Washington. We’ve worked with over 90 industry partners. We are based in Seattle, WA and financed by leading US and Asian Biotech and Tech investors including Orbimed, Trinity Ventures, Springrock, Agent Capital, iSelect, Yard Ventures, WRF and Alexandria.
We are hiring! https://cyrusbio.com/careers/
Company Details
- Employees
- 24
- Founded
- -
- Address
- 3005 1st Ave,
- Phone
- (206)258-6561
- in****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- cyrusbio.com
- Keywords
- Homology Modeling, Protein/Protein Interface Design, Enzyme/Ligand Interface Design, Protein Stabilization, Protein/Ligand docking, Protein/Protein Docking, X-ray molecular replacement.
- HQ
- Seattle, Washington
Cyrus Biotechnology Questions
Cyrus Biotechnology's helpline number is (206)258-6561
Cyrus Biotechnology's website is cyrusbio.com
Cyrus Biotechnology's LinkedIn profile is https://www.linkedin.com/company/cyrus-biotechnology
Cyrus Biotechnology has
24 employees.
View email and phone details for 24
employees at Cyrus Biotechnology.
Cyrus Biotechnology's industry is
Biotechnology Research
Cyrus Biotechnology's top competitors are
Curi Bio,
Parse Biosciences,
Shape Therapeutics Inc.,
Lumen Bioscience,
Monod Bio,
Sana Biotechnology, Inc.,
Avm Biotechnology,
Outpace Bio,
A-Alpha Bio,
Arzeda.
Cyrus Biotechnology's support email address is info@cyrusbio.com
Cyrus Biotechnology's categories are Biotechnology Research
Cyrus Biotechnology's founding year is 2014
